What is the rate of loss of response to infliximab therapy in Crohn's disease?

Am J Gastroenterol. 2009 Sep;104(9):2353-4; author reply 2354-5. doi: 10.1038/ajg.2009.375.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / economics
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Cost-Benefit Analysis
  • Crohn Disease / drug therapy
  • Drug Tolerance
  • Humans
  • Infliximab

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab